Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $21.90B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: STE stock price vs WY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WY's multiple
Needs WY P/E.
Implied fair value · at STE's multiple
Needs STE P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: STE FY 2026 (ended Mar 31, 2026) · WY FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 92% equity / 8% debt
Capital structure 73% equity / 27% debt · EV / Revenue 3.22x · EV / EBITDA 27.60x
STE carries the larger enterprise value at $23.83B against $22.22B; WY trades on the lower EV / Revenue multiple (3.22x vs 4.01x); STE on the lower EV / EBITDA (15.56x vs 27.60x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
STERIS plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
WEYERHAEUSER COMPANY · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.27x
0.65x
Net debt / EBITDA
Leverage against operating earnings
—
6.99x
Cash and equivalents
Liquid reserves on the balance sheet
—
$464.00M
Total debt
Interest-bearing obligations outstanding
$1.93B
$6.09B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Johnson & Johnson
STE vs JNJ
BAXTER INTERNATIONAL INC
STE vs BAX
BECTON DICKINSON & CO
STE vs BDX
ZIMMER BIOMET HOLDINGS, INC.
STE vs ZBH
RAYONIER INC
STE vs RYN
POTLATCHDELTIC CORP
STE vs PCH
INTERNATIONAL PAPER CO /NEW/
STE vs IP
UFP INDUSTRIES INC
STE vs UFPI
VORNADO REALTY TRUST
STE vs VNO
COSTAR GROUP, INC.
STE vs CSGP
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
